Sponsor:
NovoCure GmbH
Code:
NCT06216301
Conditions
Metastatic Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NovoTTF-200T
Pembrolizumab
Platinum based chemotherapy
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by NovoCure GmbH on 2025-04-23.